| Literature DB >> 23438143 |
Abstract
This article reviews an old drug tranexamic acid to its new use in the treatment of melasma. Its mechanism of preventing the activation of melanocyte from UV light, hormone and injured kerationcyte through the inhibition of the plasminogen activator system will be explored. The detail usage for such indication and its safety profile will also be thoroughly evaluated.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23438143 DOI: 10.1111/jocd.12026
Source DB: PubMed Journal: J Cosmet Dermatol ISSN: 1473-2130 Impact factor: 2.696